Login

Mr. CEO Unveils Embraer's New Turboprop with 250+ LOIs | Arjan Meijer - CEO of Embraer 00:10:00

Share On Facebook Share On Twitter

Arjan Meijer is Pres/CEO:Commercial Aviation at Embraer SA.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Hank Smith, CIO at Haverford Trust Co., discusses U.S. stock performance and its broader economic impact.
00:10:00
Overview of BW's Successful Construction and Operation in Japan's Nuclear Sector
00:10:00
JSA Insights – 2nd Quarter of 2022 | Jacobson & Schmitt Advisors
00:10:00
"York Capital Management CEO Jamie Dinan announces plans to wind down most of the firm's hedge funds in a letter to investors, as reported by CNBC's Leslie Picker."
00:10:00
Norwegian Mining Projects Overview by George Cavey
00:10:00
Investing the Quaker Way | Jeff Perkins, CEO, Friends Fiduciary Corporation
00:10:00
Morguard Achieves High Expectations through SAP Concur Solutions
00:10:00
Evolving Financial Planning for Client Success with Eric Simonson | Eric Simonson - CEO of Abundo Wealth
00:10:00
Assessing Brazil's Energy Sector: Transmission Auctions, Market Dynamics, and Innovations | Rui Chammas, CEO, CTEEP Companhia de Transmissao de Energia Eletrica Paulista.
00:10:00
Koen Dejonckheere Discusses Gimv's Role in Modern Healthcare | Koen Dejonckheere, CEO, GIMV Corporate.
00:10:00
This is such an insightful and transparent discussion about the challenges and transformations your company went through.
00:10:00
Goh Peng Ooi on Game Theory and the Mathematical Solutions for Global Challenges | Goh Peng Ooi , Founder, Silverlake Axis Ltd.

© 2017 - Neuhu+